Erythema annulare centrifugum-type eruption in a patient undergoing cancer vaccine immunotherapy.
We report a patient developing an immune related adverse effect from sipuleucel-T drug-induced erythema annulare centrifugum-like eruption. A brief review of the mechanism and implications of this eruption are also included.
PMID: 30677818 [PubMed - in process]
Source: Dermatol Online J - Category: Dermatology Authors: Tadros J, Rahnama-Moghadam S Tags: Dermatol Online J Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Dermatology | Immunotherapy | Prostate Cancer | Vaccines